Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,939 | 2 | 58.8% |
| Honoraria | $3,550 | 1 | 30.1% |
| Unspecified | $996.40 | 6 | 8.4% |
| Food and Beverage | $306.14 | 4 | 2.6% |
| Travel and Lodging | $10.01 | 1 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vectura Limited | $6,400 | 1 | $0 (2018) |
| La Jolla Pharmaceutical Company | $3,843 | 5 | $0 (2024) |
| TransMedics, Inc. | $996.40 | 6 | $0 (2017) |
| Zambon USA Ltd. | $539.20 | 1 | $0 (2024) |
| TETRAPHASE PHARMACEUTICALS, INC. | $23.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,089 | 2 | La Jolla Pharmaceutical Company ($3,550) |
| 2023 | $162.38 | 3 | La Jolla Pharmaceutical Company ($162.38) |
| 2022 | $130.52 | 1 | La Jolla Pharmaceutical Company ($130.52) |
| 2019 | $23.25 | 1 | TETRAPHASE PHARMACEUTICALS, INC. ($23.25) |
| 2018 | $6,400 | 1 | Vectura Limited ($6,400) |
| 2017 | $996.40 | 6 | TransMedics, Inc. ($996.40) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Honoraria | Cash or cash equivalent | $3,550.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/18/2024 | Zambon USA Ltd. | — | Consulting Fee | In-kind items and services | $539.20 | General |
| 04/21/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/21/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Travel and Lodging | In-kind items and services | $10.01 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/19/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $31.01 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/28/2022 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Food and Beverage | In-kind items and services | $130.52 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 07/26/2019 | TETRAPHASE PHARMACEUTICALS, INC. | Xerava (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: Complicated Intra-Abdominal Infections | ||||||
| 05/29/2018 | Vectura Limited | — | Consulting Fee | Cash or cash equivalent | $6,400.00 | General |
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $298.92 | Research |
| Study: Expand Lung • Category: Device | ||||||
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $199.28 | Research |
| Study: INSPIRE Lung • Category: Device | ||||||
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $199.28 | Research |
| Study: Registry Lung • Category: Device | ||||||
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $99.64 | Research |
| Study: DCD Heart • Category: Device | ||||||
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $99.64 | Research |
| Study: Expand Heart • Category: Device | ||||||
| 03/24/2017 | TransMedics, Inc. | Organ Care System (Device) | — | Cash or cash equivalent | $99.64 | Research |
| Study: Research Lung • Category: Device | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Expand Lung | TransMedics, Inc. | $298.92 | 1 |
| INSPIRE Lung | TransMedics, Inc. | $199.28 | 1 |
| Registry Lung | TransMedics, Inc. | $199.28 | 1 |
| DCD Heart | TransMedics, Inc. | $99.64 | 1 |
| Expand Heart | TransMedics, Inc. | $99.64 | 1 |
| Research Lung | TransMedics, Inc. | $99.64 | 1 |
About Dr. David Weill, MD
Dr. David Weill, MD is a Pulmonary Disease healthcare provider based in Tampa, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1629104807.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Weill, MD has received a total of $11,802 in payments from pharmaceutical and medical device companies, with $4,089 received in 2024. These payments were reported across 14 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($6,939).
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease, Transplant Surgery
- Location Tampa, FL
- Active Since 02/24/2007
- Last Updated 02/07/2019
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1629104807
Products in Payments
- GIAPREZA (Drug) $3,843
- Organ Care System (Device) $996.40
- Xerava (Drug) $23.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Tampa
Dr. Stephen Kreitzer, M.d, M.D
Pulmonary Disease — Payments: $38,725
Leonard Cosmo, Md, MD
Pulmonary Disease — Payments: $13,572
Alexandre Furman, Md, MD
Pulmonary Disease — Payments: $13,506
Ryan Floyd, D.o, D.O
Pulmonary Disease — Payments: $11,994
Marwan Odeesh, M.d, M.D
Pulmonary Disease — Payments: $11,648
Dr. Adam Katz, M.d, M.D
Pulmonary Disease — Payments: $11,373